nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—DRD4—Gilles de la Tourette syndrome	0.268	0.342	CbGaD
Aripiprazole—DRD3—Gilles de la Tourette syndrome	0.231	0.295	CbGaD
Aripiprazole—DRD2—Gilles de la Tourette syndrome	0.16	0.204	CbGaD
Aripiprazole—HTR2A—Gilles de la Tourette syndrome	0.124	0.158	CbGaD
Aripiprazole—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00347	0.0554	CbGeAlD
Aripiprazole—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00217	0.0345	CbGeAlD
Aripiprazole—Vilazodone—DRD2—Gilles de la Tourette syndrome	0.00135	0.211	CrCbGaD
Aripiprazole—HTR1E—nervous system—Gilles de la Tourette syndrome	0.0012	0.0192	CbGeAlD
Aripiprazole—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00116	0.0185	CbGeAlD
Aripiprazole—DRD4—brain—Gilles de la Tourette syndrome	0.00107	0.017	CbGeAlD
Aripiprazole—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00106	0.0168	CbGeAlD
Aripiprazole—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00102	0.0162	CbGeAlD
Aripiprazole—DRD3—nervous system—Gilles de la Tourette syndrome	0.000982	0.0156	CbGeAlD
Aripiprazole—DRD3—central nervous system—Gilles de la Tourette syndrome	0.000945	0.0151	CbGeAlD
Aripiprazole—HTR6—nervous system—Gilles de la Tourette syndrome	0.000945	0.0151	CbGeAlD
Aripiprazole—HTR1E—brain—Gilles de la Tourette syndrome	0.000921	0.0147	CbGeAlD
Aripiprazole—DRD5—nervous system—Gilles de la Tourette syndrome	0.00092	0.0147	CbGeAlD
Aripiprazole—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00091	0.0145	CbGeAlD
Aripiprazole—DRD5—central nervous system—Gilles de la Tourette syndrome	0.000886	0.0141	CbGeAlD
Aripiprazole—H1F0—midbrain—Gilles de la Tourette syndrome	0.000866	0.0138	CbGeAlD
Aripiprazole—Ziprasidone—DRD4—Gilles de la Tourette syndrome	0.000857	0.134	CrCbGaD
Aripiprazole—DRD1—midbrain—Gilles de la Tourette syndrome	0.000855	0.0136	CbGeAlD
Aripiprazole—CHRM5—nervous system—Gilles de la Tourette syndrome	0.000826	0.0132	CbGeAlD
Aripiprazole—CHRM4—brain—Gilles de la Tourette syndrome	0.000807	0.0129	CbGeAlD
Aripiprazole—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.000795	0.0127	CbGeAlD
Aripiprazole—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.000754	0.012	CbGeAlD
Aripiprazole—DRD3—brain—Gilles de la Tourette syndrome	0.000751	0.012	CbGeAlD
Aripiprazole—Ziprasidone—DRD3—Gilles de la Tourette syndrome	0.000739	0.116	CrCbGaD
Aripiprazole—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000726	0.0116	CbGeAlD
Aripiprazole—HTR6—brain—Gilles de la Tourette syndrome	0.000722	0.0115	CbGeAlD
Aripiprazole—H1F0—nervous system—Gilles de la Tourette syndrome	0.000712	0.0113	CbGeAlD
Aripiprazole—DRD5—brain—Gilles de la Tourette syndrome	0.000703	0.0112	CbGeAlD
Aripiprazole—DRD1—nervous system—Gilles de la Tourette syndrome	0.000703	0.0112	CbGeAlD
Aripiprazole—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000693	0.011	CbGeAlD
Aripiprazole—H1F0—central nervous system—Gilles de la Tourette syndrome	0.000686	0.0109	CbGeAlD
Aripiprazole—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000679	0.0108	CbGeAlD
Aripiprazole—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000677	0.0108	CbGeAlD
Aripiprazole—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000671	0.0107	CbGeAlD
Aripiprazole—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000664	0.0106	CbGeAlD
Aripiprazole—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000654	0.0104	CbGeAlD
Aripiprazole—CHRM5—brain—Gilles de la Tourette syndrome	0.000631	0.0101	CbGeAlD
Aripiprazole—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.00063	0.01	CbGeAlD
Aripiprazole—Nefazodone—SLC6A3—Gilles de la Tourette syndrome	0.000578	0.0904	CrCbGaD
Aripiprazole—ADRA1B—brain—Gilles de la Tourette syndrome	0.000577	0.00919	CbGeAlD
Aripiprazole—HTR1B—nervous system—Gilles de la Tourette syndrome	0.00057	0.00908	CbGeAlD
Aripiprazole—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000567	0.00903	CbGeAlD
Aripiprazole—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000559	0.00891	CbGeAlD
Aripiprazole—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000552	0.00879	CbGeAlD
Aripiprazole—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000549	0.00874	CbGeAlD
Aripiprazole—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000546	0.00871	CbGeAlD
Aripiprazole—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000546	0.0087	CbGeAlD
Aripiprazole—H1F0—brain—Gilles de la Tourette syndrome	0.000544	0.00867	CbGeAlD
Aripiprazole—DRD1—brain—Gilles de la Tourette syndrome	0.000537	0.00857	CbGeAlD
Aripiprazole—ADRB1—nervous system—Gilles de la Tourette syndrome	0.000536	0.00854	CbGeAlD
Aripiprazole—HTR7—midbrain—Gilles de la Tourette syndrome	0.000534	0.00852	CbGeAlD
Aripiprazole—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000531	0.00846	CbGeAlD
Aripiprazole—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000526	0.00838	CbGeAlD
Aripiprazole—HTR3A—brain—Gilles de la Tourette syndrome	0.000519	0.00827	CbGeAlD
Aripiprazole—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000518	0.00825	CbGeAlD
Aripiprazole—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.000516	0.00822	CbGeAlD
Aripiprazole—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000516	0.00822	CbGeAlD
Aripiprazole—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000515	0.0805	CrCbGaD
Aripiprazole—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000513	0.00818	CbGeAlD
Aripiprazole—Ziprasidone—DRD2—Gilles de la Tourette syndrome	0.000511	0.08	CrCbGaD
Aripiprazole—DRD2—midbrain—Gilles de la Tourette syndrome	0.000505	0.00805	CbGeAlD
Aripiprazole—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000499	0.00795	CbGeAlD
Aripiprazole—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000498	0.00794	CbGeAlD
Aripiprazole—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000497	0.00791	CbGeAlD
Aripiprazole—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000494	0.00787	CbGeAlD
Aripiprazole—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000491	0.00783	CbGeAlD
Aripiprazole—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000462	0.00736	CbGeAlD
Aripiprazole—HTR1A—nervous system—Gilles de la Tourette syndrome	0.00046	0.00733	CbGeAlD
Aripiprazole—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000444	0.00708	CbGeAlD
Aripiprazole—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000443	0.00705	CbGeAlD
Aripiprazole—HTR7—nervous system—Gilles de la Tourette syndrome	0.000439	0.007	CbGeAlD
Aripiprazole—HTR1B—brain—Gilles de la Tourette syndrome	0.000435	0.00694	CbGeAlD
Aripiprazole—CHRM2—brain—Gilles de la Tourette syndrome	0.000433	0.0069	CbGeAlD
Aripiprazole—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000424	0.00675	CbGeAlD
Aripiprazole—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000423	0.00674	CbGeAlD
Aripiprazole—HTR1D—brain—Gilles de la Tourette syndrome	0.000422	0.00672	CbGeAlD
Aripiprazole—HTR2C—brain—Gilles de la Tourette syndrome	0.000417	0.00665	CbGeAlD
Aripiprazole—DRD2—nervous system—Gilles de la Tourette syndrome	0.000415	0.00662	CbGeAlD
Aripiprazole—ADRB1—brain—Gilles de la Tourette syndrome	0.00041	0.00653	CbGeAlD
Aripiprazole—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000409	0.00652	CbGeAlD
Aripiprazole—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000408	0.0065	CbGeAlD
Aripiprazole—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000404	0.00644	CbGeAlD
Aripiprazole—DRD2—central nervous system—Gilles de la Tourette syndrome	0.0004	0.00637	CbGeAlD
Aripiprazole—SLC6A4—brain—Gilles de la Tourette syndrome	0.000396	0.00631	CbGeAlD
Aripiprazole—Ziprasidone—HTR2A—Gilles de la Tourette syndrome	0.000395	0.0618	CrCbGaD
Aripiprazole—CHRM1—brain—Gilles de la Tourette syndrome	0.000394	0.00628	CbGeAlD
Aripiprazole—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000394	0.00628	CbGeAlD
Aripiprazole—HTR2B—brain—Gilles de la Tourette syndrome	0.000392	0.00625	CbGeAlD
Aripiprazole—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000392	0.00625	CbGeAlD
Aripiprazole—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000389	0.0062	CbGeAlD
Aripiprazole—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000356	0.0557	CrCbGaD
Aripiprazole—CHRM3—brain—Gilles de la Tourette syndrome	0.000353	0.00562	CbGeAlD
Aripiprazole—HTR1A—brain—Gilles de la Tourette syndrome	0.000351	0.0056	CbGeAlD
Aripiprazole—HTR7—brain—Gilles de la Tourette syndrome	0.000336	0.00535	CbGeAlD
Aripiprazole—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000333	0.00531	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—Gilles de la Tourette syndrome	0.000332	0.0519	CrCbGaD
Aripiprazole—HRH1—nervous system—Gilles de la Tourette syndrome	0.000328	0.00523	CbGeAlD
Aripiprazole—ADRA1A—brain—Gilles de la Tourette syndrome	0.000324	0.00516	CbGeAlD
Aripiprazole—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000322	0.00514	CbGeAlD
Aripiprazole—DRD2—brain—Gilles de la Tourette syndrome	0.000318	0.00506	CbGeAlD
Aripiprazole—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000316	0.00503	CbGeAlD
Aripiprazole—KCNH2—brain—Gilles de la Tourette syndrome	0.000313	0.00499	CbGeAlD
Aripiprazole—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.00031	0.00494	CbGeAlD
Aripiprazole—ADRA2C—brain—Gilles de la Tourette syndrome	0.000309	0.00492	CbGeAlD
Aripiprazole—Trazodone—HTR2A—Gilles de la Tourette syndrome	0.000307	0.0481	CrCbGaD
Aripiprazole—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000274	0.00437	CbGeAlD
Aripiprazole—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000264	0.0042	CbGeAlD
Aripiprazole—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000255	0.0398	CrCbGaD
Aripiprazole—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000254	0.00404	CbGeAlD
Aripiprazole—HRH1—brain—Gilles de la Tourette syndrome	0.000251	0.004	CbGeAlD
Aripiprazole—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00025	0.00398	CbGeAlD
Aripiprazole—ADRA2A—brain—Gilles de la Tourette syndrome	0.000246	0.00393	CbGeAlD
Aripiprazole—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000244	0.00389	CbGeAlD
Aripiprazole—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00024	0.00383	CbGeAlD
Aripiprazole—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000218	0.00348	CbGeAlD
Aripiprazole—HTR2A—brain—Gilles de la Tourette syndrome	0.000209	0.00334	CbGeAlD
Aripiprazole—Perphenazine—HTR2A—Gilles de la Tourette syndrome	0.000197	0.0308	CrCbGaD
Aripiprazole—CYP2D6—brain—Gilles de la Tourette syndrome	0.000191	0.00304	CbGeAlD
Aripiprazole—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00018	0.00286	CbGeAlD
Aripiprazole—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000173	0.00276	CbGeAlD
Aripiprazole—ABCB1—brain—Gilles de la Tourette syndrome	0.000137	0.00219	CbGeAlD
Aripiprazole—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.76e-05	0.000187	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.75e-05	0.000186	CbGpPWpGaD
Aripiprazole—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.74e-05	0.000186	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.73e-05	0.000185	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.72e-05	0.000185	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.7e-05	0.000183	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.7e-05	0.000183	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.68e-05	0.000182	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.67e-05	0.000181	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.64e-05	0.000179	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.64e-05	0.000179	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.63e-05	0.000179	CbGpPWpGaD
Aripiprazole—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.62e-05	0.000178	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.62e-05	0.000177	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000177	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.6e-05	0.000176	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.59e-05	0.000176	CbGpPWpGaD
Aripiprazole—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.56e-05	0.000174	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.53e-05	0.000171	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.52e-05	0.000171	CbGpPWpGaD
Aripiprazole—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.52e-05	0.000171	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.51e-05	0.00017	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.51e-05	0.00017	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.5e-05	0.000169	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.5e-05	0.000169	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.49e-05	0.000169	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.48e-05	0.000168	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000168	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.47e-05	0.000168	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.47e-05	0.000167	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.46e-05	0.000167	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.45e-05	0.000166	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000166	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.45e-05	0.000166	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.44e-05	0.000166	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.44e-05	0.000165	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.41e-05	0.000163	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	2.4e-05	0.000163	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.4e-05	0.000163	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000161	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.37e-05	0.000161	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.36e-05	0.00016	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.35e-05	0.00016	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.35e-05	0.000159	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.34e-05	0.000159	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.3e-05	0.000156	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000155	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.29e-05	0.000155	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.29e-05	0.000155	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.28e-05	0.000155	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.28e-05	0.000154	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.26e-05	0.000153	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.25e-05	0.000153	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.25e-05	0.000152	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.24e-05	0.000152	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.24e-05	0.000152	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.24e-05	0.000152	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.24e-05	0.000152	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.23e-05	0.000151	CbGpPWpGaD
Aripiprazole—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.23e-05	0.000151	CbGpPWpGaD
Aripiprazole—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.23e-05	0.000151	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.22e-05	0.000151	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.22e-05	0.00015	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.00015	CbGpPWpGaD
Aripiprazole—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.21e-05	0.00015	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.21e-05	0.00015	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.21e-05	0.00015	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.2e-05	0.000149	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.19e-05	0.000148	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.18e-05	0.000148	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.18e-05	0.000148	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.17e-05	0.000147	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.17e-05	0.000147	CbGpPWpGaD
Aripiprazole—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000147	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.14e-05	0.000145	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.14e-05	0.000145	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.14e-05	0.000145	CbGpPWpGaD
Aripiprazole—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.13e-05	0.000144	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.13e-05	0.000144	CbGpPWpGaD
Aripiprazole—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.1e-05	0.000142	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.08e-05	0.000141	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.07e-05	0.00014	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.05e-05	0.000139	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.04e-05	0.000138	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.04e-05	0.000138	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.04e-05	0.000138	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.03e-05	0.000138	CbGpPWpGaD
Aripiprazole—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.000138	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.03e-05	0.000138	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.03e-05	0.000138	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.03e-05	0.000137	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.02e-05	0.000137	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.000137	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.000137	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.02e-05	0.000137	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.02e-05	0.000137	CbGpPWpGaD
Aripiprazole—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.01e-05	0.000136	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.01e-05	0.000136	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.01e-05	0.000136	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2e-05	0.000136	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2e-05	0.000135	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.99e-05	0.000135	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	1.99e-05	0.000135	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.98e-05	0.000134	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.98e-05	0.000134	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.97e-05	0.000134	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.97e-05	0.000133	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000133	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.95e-05	0.000132	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.94e-05	0.000132	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.93e-05	0.000131	CbGpPWpGaD
Aripiprazole—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.92e-05	0.00013	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.91e-05	0.000129	CbGpPWpGaD
Aripiprazole—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.89e-05	0.000128	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.89e-05	0.000128	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.89e-05	0.000128	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.87e-05	0.000127	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.000126	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000125	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.85e-05	0.000125	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.85e-05	0.000125	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.84e-05	0.000125	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.84e-05	0.000125	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.83e-05	0.000124	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.83e-05	0.000124	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.83e-05	0.000124	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.83e-05	0.000124	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.000124	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.82e-05	0.000123	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.81e-05	0.000123	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.81e-05	0.000123	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.8e-05	0.000122	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	1.8e-05	0.000122	CbGpPWpGaD
Aripiprazole—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	1.78e-05	0.000121	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.78e-05	0.000121	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.78e-05	0.000121	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.75e-05	0.000119	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000118	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.73e-05	0.000117	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000117	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.72e-05	0.000117	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000116	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.71e-05	0.000116	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.71e-05	0.000116	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.7e-05	0.000116	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.7e-05	0.000116	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.69e-05	0.000115	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000114	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.67e-05	0.000113	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.66e-05	0.000112	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.65e-05	0.000112	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.65e-05	0.000112	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.64e-05	0.000111	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.63e-05	0.000111	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.62e-05	0.00011	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.61e-05	0.000109	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.6e-05	0.000108	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.58e-05	0.000107	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.57e-05	0.000106	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.57e-05	0.000106	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.56e-05	0.000106	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.56e-05	0.000105	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000105	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000105	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.54e-05	0.000104	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.5e-05	0.000102	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.49e-05	0.000101	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.48e-05	0.0001	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.47e-05	9.96e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.46e-05	9.9e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.45e-05	9.82e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.45e-05	9.82e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.45e-05	9.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.45e-05	9.81e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.43e-05	9.67e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.42e-05	9.64e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.42e-05	9.61e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.42e-05	9.61e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.41e-05	9.57e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.4e-05	9.52e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.4e-05	9.48e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.4e-05	9.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.4e-05	9.46e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.39e-05	9.42e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.36e-05	9.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.35e-05	9.16e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.35e-05	9.14e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.33e-05	9.02e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.32e-05	8.95e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.32e-05	8.91e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.31e-05	8.89e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.31e-05	8.87e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.3e-05	8.79e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.29e-05	8.75e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.29e-05	8.75e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.29e-05	8.72e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.28e-05	8.69e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.27e-05	8.61e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.27e-05	8.59e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.26e-05	8.56e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.26e-05	8.52e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.23e-05	8.31e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.22e-05	8.28e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.21e-05	8.18e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.2e-05	8.16e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.2e-05	8.15e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.2e-05	8.13e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.2e-05	8.11e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.2e-05	8.1e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.19e-05	8.09e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.19e-05	8.07e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.19e-05	8.04e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.18e-05	8.03e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.18e-05	8.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.18e-05	7.98e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.17e-05	7.94e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.17e-05	7.92e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.17e-05	7.9e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.16e-05	7.87e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.16e-05	7.87e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.15e-05	7.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.15e-05	7.77e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.14e-05	7.75e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.13e-05	7.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.1e-05	7.44e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.09e-05	7.4e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.09e-05	7.39e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.09e-05	7.38e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.09e-05	7.36e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.08e-05	7.33e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.08e-05	7.32e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.07e-05	7.26e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.07e-05	7.24e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.07e-05	7.22e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.03e-05	6.97e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.02e-05	6.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	9.93e-06	6.73e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.25e-06	6.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.17e-06	6.21e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.85e-06	6e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.8e-06	5.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.56e-06	5.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	8.43e-06	5.71e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.77e-06	5.26e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.63e-06	5.17e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.6e-06	5.15e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.58e-06	5.14e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.51e-06	5.09e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.48e-06	5.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.95e-06	4.71e-05	CbGpPWpGaD
